Clinical Trial Update: Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of combined omega-3-acid ethyl esters (Omacor) and simvastatin in adults with hypertriglyceridemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Omacor (omega-3-acid ethyl esters)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertriglyceridemia | Phase 3 | Status: COMPLETED